Does an alternative sunitinib dosing schedule really improve survival outcomes over a conventional dosing schedule in patients with metastatic renal cell carcinoma? An updated systematic review and meta-analysis

제목
Does an alternative sunitinib dosing schedule really improve survival outcomes over a conventional dosing schedule in patients with metastatic renal cell carcinoma? An updated systematic review and meta-analysis
저자
Chung Doo Yong
학회명
AUA 2020